Clinical Trial Update: Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sequential IV/PO moxifloxacin to IV levofloxacin plus IV ceftriaxone followed by oral levofloxacin in adults with community-acquired p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Avelox (moxifloxacin)
• Levaquin (levofloxacin)
• Rocephin (Ceftriaxone)

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Phase 3 | Status: COMPLETED